No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Northwell Health Makes History: 1st in the US to Immunize Frontline Workers Against COVID-19

Editor: What To Know

  • We're in a pandemic and so we all need to do our part to put an end to the pandemic and to not give up too soon.
  • “This truly is a historic day for science and humanity, one in which we here in New York and across the United States have been waiting for quite some time.
  • Northwell also stocked up on extra needles, gloves, swabs to help distribute the vaccine once ready, and the health system has been working hand-in-hand with state and federal officials for a rollout.

December 14, 2020

Northwell Health, after nearly 10 months of managing an illness that has killed nearly 300,000 and sickened more than 15 million Americans, today took a major step toward the end of the COVID-19 pandemic.

Northwell Health system made history by vaccinating the first person in the United States against COVID-19, when it injected Pfizer Inc.’s medication into Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center.

Northwell Health First in the U.S. to administer COVID-19 vaccine

Ms. Lindsay’s participation kick-started a long-anticipated vaccination deployment program throughout the US, as well as the first phase of Northwell’s three-stage rollout to essential frontline hospital personnel. Physicians, nurses and any staff member working in direct contact with COVID-19 patients will also soon receive the first of the two-dose regimen.

“Today is V-Day in our fight against COVID-19,” said Michael Dowling, Northwell president and CEO. “This truly is a historic day for science and humanity, one in which we here in New York and across the United States have been waiting for quite some time.”

After receiving the injection, Ms. Lindsay said: “I feel great. It didn’t feel any different that when receiving the annual influenza vaccine. I would like to thank all the frontline workers, all my colleagues who’ve been doing a yeoman’s job to fight this pandemic all over the world. I feel hopeful today.

“I feel relieved. I hope this marks the beginning to the end of a very painful time in our history. I want to instill public confidence that the vaccine is safe. We’re in a pandemic and so we all need to do our part to put an end to the pandemic and to not give up too soon. There’s light at the end of the tunnel.”

Northwell Health received a limited supply of a few thousands doses — to be spread among eight hospitals — of Pfizer’s vaccine, which will require two injections 21 days apart. The vaccine has demonstrated 95-percent efficacy against infection with minimal side effects, and works on messenger RNA (mRNA) technology, which has been in development for several years. mRNA instructs cells in the body to make different proteins.

To vaccinate team members, Northwell Health has prepared a three-phase prioritization matrix to help deploy the vaccine to its over 74,000 team members. The plan factors in a person’s work/geographic area, department specialty, job function and age.

To prepare, Northwell Health invested in procuring more than 20 -70F freezers, which can store about 250,000 doses each. Northwell also stocked up on extra needles, gloves, swabs to help distribute the vaccine once ready, and the health system has been working hand-in-hand with state and federal officials for a rollout.

“This is a major milestone in our battle against COVID-19 and a remarkable effort by our researchers, scientists and health care providers,” said Mark Jarrett, MD, Northwell’s chief quality officer and deputy chief medical officer. “Our detailed plan will push the seamless vaccination of these brave health care workers. We are very excited to enter the final stage of this pandemic.”

Mr. Dowling added: “COVID-19 took our loved ones, disrupted our lives and forced us to deal with unthinkable circumstances. But hope brings prosperity and we never ended our fight. We never did wave the white flag.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy